| Q37838202 | A basis for the pathological oscillations in basal ganglia: the crucial role of dopamine |
| Q48658263 | A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. |
| Q42515919 | Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys |
| Q42527647 | Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents |
| Q41059064 | Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells |
| Q42527914 | Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. |
| Q47095276 | Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease |
| Q88802477 | Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron |
| Q57778947 | Adenosine A2A Receptors: Localization and Function |
| Q36083482 | Adenosine and brain function |
| Q34093950 | Adenosine as a volume transmission signal. A feedback detector of neuronal activation |
| Q35172268 | Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics. |
| Q35652332 | Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: potential targets for a new therapeutic approach. |
| Q37719729 | Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders. |
| Q41624006 | Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia |
| Q57708611 | Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease |
| Q43258482 | Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum |
| Q48394771 | Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum |
| Q34088910 | Anatomy, physiology, and pharmacology of the basal ganglia |
| Q91863400 | Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A2A Receptor Antagonist |
| Q40700867 | Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization |
| Q48096397 | Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors |
| Q36471008 | Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice |
| Q36865810 | Caffeine stimulates locomotor activity in the mammalian spinal cord via adenosine A1 receptor-dopamine D1 receptor interaction and PKA-dependent mechanisms. |
| Q48405794 | Caffeine--an atypical drug of dependence |
| Q46728012 | Caffeine-induced hyperactivity in the horse: comparisons of drug and metabolite concentrations in blood and cerebrospinal fluid |
| Q42478324 | Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system |
| Q93017219 | Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum |
| Q48624366 | Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas |
| Q28204434 | Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors |
| Q37342898 | Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys |
| Q34419833 | Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease |
| Q48539838 | Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study |
| Q38111703 | Dopamine and renal function and blood pressure regulation |
| Q48229048 | Dopamine depresses glutamatergic synaptic transmission in the rat parabrachial nucleus in vitro |
| Q48679822 | Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux |
| Q28358803 | Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia |
| Q57708646 | Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2Areceptors in dopamine D2receptor regulation in the rat dopamine-denervated striatum |
| Q44667699 | Endogenous dopamine modulates corticopallidal influences via GABA. |
| Q28579277 | Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum |
| Q36155216 | Expression of striatal adenosine and dopamine receptors in mice deficient in the p50 subunit of NF-kappaB |
| Q34330022 | Extrastriatal dopaminergic circuits of the Basal Ganglia |
| Q33924857 | Functional changes of the basal ganglia circuitry in Parkinson's disease. |
| Q37915703 | Functional connectivity and integrative properties of globus pallidus neurons |
| Q48323311 | Functional neuroanatomy of the basal ganglia as studied by dual-probe microdialysis |
| Q28589879 | Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors |
| Q48617737 | Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons |
| Q24651562 | Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum |
| Q42513220 | Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission |
| Q74746934 | Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia |
| Q54707901 | Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. |
| Q73815926 | Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats |
| Q44331965 | Modulation of adenosine concentration by opioid receptor agonists in rat striatum |
| Q48152534 | Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia |
| Q48264314 | On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat. |
| Q47642330 | Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome. |
| Q55266660 | Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy. |
| Q36615985 | Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins. |
| Q36356787 | Role of adenosine in the control of homosynaptic plasticity in striatal excitatory synapses. |
| Q43047681 | Role of adenosine receptor subtypes in methamphetamine reward and reinforcement. |
| Q73450854 | Roles of adenosine A(1) and A(2A) receptors in the expression and development of methamphetamine-induced sensitization |
| Q74578998 | Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats |
| Q46923737 | Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons |
| Q42443070 | Substantia nigra pars reticulata GABA is involved in the regulation of operant lever pressing: pharmacological and microdialysis studies |
| Q57896358 | The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease |
| Q41527844 | The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans |
| Q32065404 | The cortico-basal ganglia-thalamocortical circuit with synaptic plasticity. II. Mechanism of synergistic modulation of thalamic activity via the direct and indirect pathways through the basal ganglia |
| Q36791342 | Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilat |
| Q35009106 | Ultrastructural localization and function of dopamine D1-like receptors in the substantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys. |
| Q35846784 | Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticula |